Steely Comments on Effects of Revised FFCRA Regulations

Foley & Lardner LLP partner Kyle Faget is featured in four Medtech Insight articles evaluating the medtech industry’s major developments in 2025 and examining 2026 regulatory challenges.

Foley & Lardner LLP partner James Lundy addressed the impact a ruling from the U.S. Supreme Court would have on the securities industry in the Law360, “SEC To Lean On Congress As Defense In High Court Case.”

Foley & Lardner LLP partner Natasha Allen shared insight on how companies are navigating AI regulations in the Silicon Valley Business Journal article, “Silicon Valley companies navigate AI adoption as state and federal rules remain uncertain.”